E. Sebbag
- Rehabilitation top 10%
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- T-cell and B-cell Immunology 2
-
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 1
-
- Chronic Lymphocytic Leukemia Research 1
-
- Health Systems, Economic Evaluations, Quality of Life 1
-
- Surgical Simulation and Training 1
-
- Innovations in Medical Education 1
- Co-authors
- Renaud FeltenLaurent ArnaudJean SibiliaHervé DevilliersFlora SagezMarc ScherlingerPhilippe MertzWei Tang
- Journals
- Annals of the Rheumatic Diseases (2 papers)Drug Discovery Today (1 paper)Best Practice & Research Clinical Rheumatology (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
E. Sebbag
6 papers receiving 249 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Rehabilitation 36
- Pharmacology 81
- Rheumatology 61
- Medical Laboratory Technology 5
- Orthopedics and Sports Medicine 24
Countries citing papers authored by E. Sebbag
This map shows the geographic impact of E. Sebbag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Sebbag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Sebbag more than expected).
Fields of papers citing papers by E. Sebbag
This network shows the impact of papers produced by E. Sebbag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Sebbag. The network helps show where E. Sebbag may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Sebbag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 16 | |
| 6 | 2021 | 6 | |
| 7 | The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Databasebreakdown → | 2019 | 219 |
About E. Sebbag
E. Sebbag is a scholar working on Genetics, Oncology, Rehabilitation, Pathology and Forensic Medicine and Immunology, having authored 7 papers that have together received 252 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (2 papers), T-cell and B-cell Immunology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Surgical Simulation and Training (1 paper), Innovations in Medical Education (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Rehabilitation (36 citations), Pharmacology (81 citations), Rheumatology (61 citations), Medical Laboratory Technology (5 citations) and Orthopedics and Sports Medicine (24 citations). E. Sebbag has collaborated with scholars based in France and United States. Frequent co-authors include Renaud Felten, Laurent Arnaud, Jean Sibilia, Hervé Devilliers, Flora Sagez, Marc Scherlinger, Philippe Mertz, Wei Tang, Seyyid Baloglu and Christine Tranchant. Their work appears in journals such as Annals of the Rheumatic Diseases, Drug Discovery Today, Best Practice & Research Clinical Rheumatology, Annals of Oncology and BMC Medical Education.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.